Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board
Repair Biotechnologies, Inc. (https://www.repairbiotechnologies.com/), a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque, today announced the appointments of Ronald P. Karlsberg, MD,...
Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models
Following favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis...